Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 49

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Angiotensin-(1–9) prevents cardiomyocyte hypertrophy by controlling mitochondrial dynamics via miR-129-3p/PKIA pathway

Sotomayor-Flores, Cristian, Rivera-Mejías, Pablo, Vásquez-Trincado, César, López-Crisosto, Camila, Morales, Pablo E., Pennanen, Christian, Polakovicova, Iva, Aliaga-Tobar, Víctor, García, Lorena, Roa, Juan Carlos, Rothermel, Beverly A., Maracaja-Coutinho, Vinicius, Ho-Xuan, Hung, Meister, Gunter, Chiong, Mario, Ocaranza, María Paz, Corvalán, Alejandro H., Parra, Valentina, Lavandero, Sergio · 2020 · Cell Death & Differentiation

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41418-020-0522-3

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Research works printed but not linked: 63

  1. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. A novel angiotensin-converting enzyme–related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 2000;87:1–9. · DOI · Paper page
  2. Ocaranza P, Godoy I, Jalil JE, Varas M, Collantes P, Pinto M, et al. Enalapril attenuates downregulation of angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat. Hypertension. 2006;572–8. · DOI · Paper page
  3. Ocaranza MP, Lavandero S, Jalil JE, Moya J, Pinto M, Novoa U, et al. Angiotensin-(1–9) regulates cardiac hypertrophy in vivo and in vitro. J Hypertens. 2010;28:1054–64. · DOI
  4. Ocaranza P, Rivera P, Novoa U, Pinto M, Gonza L, Chiong M, et al. Rho kinase inhibition activates the homologous angiotensin- converting enzyme-angiotensin-(1–9) axis in experimental hypertension. J Hypertens. 2011;29:706–15. · DOI
  5. Flores-Munoz M, Work LM, Douglas K, Denby L, Dominiczak AF, Graham D, et al. Angiotensin-(1-9) attenuates cardiac fibrosis in the stroke-prone spontaneously hypertensive rat via the angiotensin type 2 receptor. Hypertension. 2012;59:300–7. · DOI
  6. Flores-Muñoz M, Smith NJ, Haggerty C, Milligan G, Nicklin SA. Angiotensin1-9 antagonises pro-hypertrophic signalling in cardiomyocytes via the angiotensin type 2 receptor. J Physiol. 2011;4:939–51. · DOI
  7. Fattah C, Nather K, McCarroll CS, Hortigon-Vinagre MP, Zamora V, Flores-Munoz M, et al. gene therapy with angiotensin-(1-9) preserves left ventricular systolic function after myocardial infarction. J Am Coll Cardiol. 2016;68:2652–66. · DOI
  8. Xu H, Zhang Y, Sun J, Wei J, Sun L, Zhang J. Effect of distinct sources of Ca2+ on cardiac hypertrophy in cardiomyocytes. Exp Biol Med. (Maywood). 2012;237:271–8. · doi:10.1258/ebm.2011.011273
  9. Shimizu I, Minamino T. Physiological and pathological cardiac hypertrophy. J Mol Cell Cardiol. 2016;97:245–62. · DOI · Paper page
  10. Pennanen C, Parra V, Lopez-Crisosto C, Morales PE, Del Campo A, Gutierrez T, et al. Mitochondrial fission is required for cardiomyocyte hypertrophy via a Ca2+ -calcineurin signalling pathway. J Cell Sci. 2014;127:1–33. · DOI
  11. Houser SR, Molkentin JD. Does contractile Ca2+ control calcineurin-NFAT signaling and pathological hypertrophy in cardiac myocytes? Sci Signal. 2008;1:1–7. · DOI
  12. Gutiérrez T, Parra V, Troncoso R, Pennanen C, Contreras-Ferrat A, Vasquez-Trincado C, et al. Alteration in mitochondrial Ca2+ uptake disrupts insulin signaling in hypertrophic cardiomyocytes. Cell Commun Signal. 2014;12:1–14. · DOI
  13. López-Crisosto C, Bravo-Sagua R, Rodriguez-Peña M, Mera C, Castro PF, Quest AFG, et al. ER-to-mitochondria miscommunication and metabolic diseases. Biochim Biophys Acta. 2015;1852:2096–105. · DOI
  14. Bartel DP, Lee R, Feinbaum R. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97. · DOI
  15. Hwang H, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer. 2007;94:776–80. · DOI · Paper page
  16. Lau NC, Lim LP, Weinstein EG, Bartel DP, Lau NC, Lim LP, et al. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science. 2001;294:858–62. · DOI · Paper page
  17. Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B, et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature. 2000;408:1998–2001. · DOI · Paper page
  18. Wu X, Piper-Hunter MG, Crawford M, Nuovo GJ, Clay B, Otterson GA, et al. Micrornas in the pathogenesis of lung cancer. J Thorac Oncol. 2009;4:1028–34. · DOI
  19. Yang B, Lu Y, Wang Z. MicroRNAs and apoptosis: implications in the molecular therapy of human disease. Clin Exp Pharm Physiol. 2009;36:951–60. · DOI
  20. Zorio E, Medina P, Rueda J, Millán JM, Arnau MA, Beneyto M, et al. Insights into the role of microRNAs in cardiac diseases: from biological signalling to therapeutic targets. Cardiovasc Hematol Agents Med Chem. 2009;7:82–90. · DOI
  21. Galasso M, Sana ME, Volinia S. Non-coding RNAs: a key to future personalized molecular therapy? Genome Med. 2010;2:1–10. · DOI
  22. Van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA. 2006;103:18255–60. · DOI · Paper page
  23. Lu Y, Zhang Y, Wang N, Pan Z, Gao X, Zhang F, et al. MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation. 2010;122:2378–87. · DOI · Paper page
  24. Parra V, Eisner V, Chiong M, Criollo A, Moraga F, Jaimovich E, et al. Changes in mitochondrial dynamics during ceramide-induced cardiomyocyte early apoptosis. Cardiovasc Res. 2008;77:387–97. · DOI · Paper page
  25. Parra V, Verdejo HE, Iglewski M, Del Campo A, Troncoso R, Jones D, et al. Insulin stimulates mitochondrial fusion and function in cardiomyocytes via the Akt-mTOR-NFkB-Opa-1 signaling pathway. Diabetes. 2014;63:75–88. · DOI · Paper page
  26. Yu T, Sheu S-S, Robotham JL, Yoon Y. Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species. Cardiovasc Res. 2008;79:341–51. · DOI · Paper page
  27. Munoz JP, Chiong M, García L, Troncoso R, Toro B, Pedrozo Z, et al. Iron induces protection and necrosis in cultured cardiomyocytes: role of reactive oxygen species and nitric oxide. Free Radic Biol Med. 2010;48:526–34. · DOI
  28. Contreras-Ferrat A, Toro B, Bravo-Sagua R, Parra V, Vasquez-Trincado C, Ibarra C, et al. An Inositol 1,4,5-triphosphate (IP3)-IP3 receptor pathway is required for insulin-stimulated glucose transporter 4 translocation and glucose uptake in cardiomyocytes. Endocrinology. 2010;151:4665–77. · DOI
  29. Chiong M, Parra V, Eisner V, Ibarra C, Maldonado C, Criollo A, et al. Parallel activation of Ca2+-induced survival and death pathways in cardiomyocytes by sorbitol-induced hyperosmotic stress. Apoptosis. 2010;15:887–903. · DOI
  30. Rojas-Rivera D, Díaz-Elizondo J, Parra V, Salas D, Contreras A, Toro B, et al. Regulatory volume decrease in cardiomyocytes is modulated by calcium influx and reactive oxygen species. FEBS Lett. 2009;583:3485–92. · DOI
  31. Bravo-Sagua R, López-Crisosto C, Parra V, Rodriguez M, Rothermel BA, Quest AFG, et al. mTORC1 inhibitor rapamycin and ER stressor tunicamycin induce differential patterns of ER- mitochondria coupling. Sci Rep. 2016;6:1–12. · DOI
  32. Manders EMM, Verbeek FJ, Aten JA. Measurement of co-localization of objects in dual-colour confocal images. J Microsc. 1993;169:375–82. · DOI · Paper page
  33. Parra V, Altamirano F, Hernandez-Fuentes CP, Tong D, Kyrychenko V, Rotter D, et al. Down syndrome critical region 1 gene, rcan1, helps maintain a more fused mitochondrial network. Circ Res. 2018;122:1–26. · DOI
  34. Benes V, Collier P, Kordes C, Stolte J, Rausch T, Muckentaler MU, et al. Identification of cytokine- induced modulation of microRNA expression and secretion as measured by a novel microRNA specific qPCR assay. Sci Rep. 2015;5:1–14. · DOI
  35. Hasler D, Lehmann G, Murakawa Y, Rajewsky N, Landthaler M, Meister G, et al. The lupus autoantigen La prevents Mis-channeling of t-RNA fragments into the human microRNA pathway. Mol Cell. 2016;63:110–24. · DOI
  36. Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for illumina sequence data. Bioinformatics. 2014;30:2114–20. · DOI · Paper page
  37. Orell A, Tripp V, Aliaga-Tobar V, Albers S, Maracaja-Coutinho V, Randau L. A regulatory RNA is involved in RNA duplex formation and biofilm regulation in Sulfolobus acidocaldarius. Nucleic Acids Res. 2018;46:4794–806. · doi:10.1093/nar/gky144
  38. Matamala JM, Arias-Carrasco R, Sanchez C, Uhrig M, Matus S, Maracaja-Coutinho V, et al. Genome-wide circulating microRNA expression profiling reveals potential biomarkers for amyotrophic lateral sclerosis. Neurobiol Aging. 2018;64:123–38. · DOI
  39. Hubbard T, Barker D, Birney E, Cameron G, Chen Y, Clark L, et al. The Ensembl genome database project. Nucleic Acids Res. 2002;30:38–41. · DOI · Paper page
  40. Langmead B. Aligning short sequencing reads with Bowtie. Curr Protoc Bioinforma. 2010;11:1–24.
  41. Quinlan AR. BEDTools: the Swiss-army tool for genome feature analysis. Curr Protoc Bioinforma. 2015;47:12.1–12.34.
  42. Dueck A, Ziegler C, Eichner A, Berezikov E, Meister G. microRNAs associated with the different human Argonaute proteins. Nucleic Acids Res. 2012;40:9850–62. · DOI · Paper page
  43. Pall GS, Hamilton AJ. Improved northern blot method for enhanced detection of small RNA. Nat Protoc. 2008;3:1077–84. · DOI · Paper page
  44. Nam J, Rissland OS, Koppstein D, Abreu-Goodger C, Jan CH, Agarwal V, et al. Global analyses of the effect of different cellular contexts on microRNA targeting. Mol Cell. 2015;53:1031–43. · DOI · Paper page
  45. Dweep H, Gretz N. miRWalk2.0: a comprehensive atlas of microRNA-target interactions. Nat Methods. 2015;12:697. · DOI · Paper page
  46. Ocaranza MP, Moya J, Barrientos V, Alzamora R, Hevia D, Morales C, et al. Angiotensin-(1-9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis. J Hypertens. 2014;32:771–83. · DOI
  47. Fyhrquist F, Saijonmaa O. Renin-angiotensin system revisited. J Intern Med. 2008;264:224–34. · DOI · Paper page
  48. Yoon Y, Krueger EW, Oswald BJ, Mcniven MA. The mitochondrial protein hFis1 regulates mitochondrial fission in mammalian cells through an interaction with the dynamin-like protein DLP1. Mol Cell Biol. 2003;23:5409–20. · DOI · Paper page
  49. Cribbs JT, Strack S. Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulatesmitochondrial fission and cell death. EMBO Rep. 2007;8:939–44. · DOI · Paper page
  50. Chang C-R, Blackstone C. Cyclic AMP-dependent protein kinase phosphorylation of drp1 regulates its gtpase activity and mitochondrial morphology. J Biol Chem. 2007;282:21583–7. · DOI · Paper page
  51. Santel A, Frank S. Shaping mitochondria: the complex posttranslational regulation of the mitochondrial fission protein DRP1. IUBMB Life. 2008;60:448–55. · DOI
  52. Eisner V, Parra V, Lavandero S, Hidalgo C, Jaimovich E. Mitochondria fine-tune the slow Ca2+ transients induced by electrical stimulation of skeletal myotubes. Cell Calcium. 2010;48:358–70. · DOI
  53. Rothermel BA, Vega RB, Williams RS. The role of modulatory calcineurin-interacting proteins in calcineurin signaling. Trends Cardiovasc Med. 2003;13:15–21. · DOI · Paper page
  54. Giorgi C, De Stefani D, Bononi A, Rizzuto R, Pinton P. Structural and functional link between the mitochondrial network and the endoplasmic reticulum. Int J Biochem Cell Biol. 2010;41:1817–27. · DOI · Paper page
  55. Bravo-Sagua R, Parra V, Ortiz-Sandoval C, Navarro-Marquez M, Rodriguez AE, Díaz-Valdivia N, et al. Caveolin-1 impairs PKA-DRP1-mediated remodelling of ER–mitochondria communication during the early phase of ER stress. Cell Death Differ. 2019;1:1195–212. · DOI
  56. Ding J, Li X, Hu H. TarPmiR: a new approach for microRNA target site prediction. Bioinformatics. 2016;32:2768–75. · DOI · Paper page
  57. Olsen SR, Uhler MD. Inhibition of protein kinase-A by overexpression of the cloned human protein kinase inhibitor. Mol Endocrinol. 1991;5:1246–56. · DOI
  58. Vásquez-Trincado C, García-Carvajal I, Pennanen C, Parra V, Hill JA, Rothermel BA, et al. Mitochondrial dynamics, mitophagy and cardiovascular disease. J Physiol. 2016;3:509–25. · DOI · Paper page
  59. Chen Y, Liu Y, Dorn GW II. Mitochondrial fusion is essential for organelle function and cardiac homeostasis. Circ Res. 2011;109:1327–31. · DOI · Paper page
  60. Chen L, Liu T, Tran A, Lu X, Tomilov AA, Davies V, et al. OPA1 mutation and late-onset cardiomyopathy: mitochondrial dysfunction and mtDNA instability. J Am Heart Assoc. 2012;1:1–12. · DOI · Paper page
  61. Ashrafian H, Docherty L, Leo V, Towlson C, Neilan M, Lygate CA, et al. A Mutation in the mitochondrial fission gene dnm1l leads to cardiomyopathy. Plos Genet. 2010;6:1–18. · DOI
  62. Givvimani S, Munjal C, Tyagi N, Sen U, Metreveli N, Tyagi SC. Mitochondrial division/mitophagy inhibitor (mdivi) ameliorates pressure overload induced heart failure. PLoS ONE. 2012;7:e32388. · DOI · Paper page
  63. Jeppesen PL, Christensen GL, Mikael S, Yaël Nossent A, Jensen Bronnum H, Andersen DC, et al. Angiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytes. Br J Pharm. 2011;164:394–404. · DOI

Cited by

See all 49

Metadata

Authors
Sotomayor-Flores, C., Rivera-Mejías, P., Vásquez-Trincado, C., López-Crisosto, C., Morales, P. E., Pennanen, C., Polakovicova, I., Aliaga-Tobar, V., García, L., Roa, J. C., Rothermel, B. A., Maracaja-Coutinho, V., Ho-Xuan, H., Meister, G., Chiong, M., Ocaranza, M. P., Corvalán, A. H., Parra, V., & Lavandero, S.
Venue
Cell Death & Differentiation
Published
2020-03-09
Volume
27
Issue
9
Pages
2586-2604
ISSN
  • 1350-9047
  • 1476-5403
Cited by
49
References
13
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Angiotensin-(1–9) prevents cardiomyocyte hypertrophy by controlling mitochondrial dynamics via miR-129-3p/PKIA pathway. https://app.cochat.ai/papers/10.1038/s41418-020-0522-3
The paper
Sotomayor-Flores, C., Rivera-Mejías, P., Vásquez-Trincado, C., López-Crisosto, C., Morales, P. E., Pennanen, C., Polakovicova, I., Aliaga-Tobar, V., García, L., Roa, J. C., Rothermel, B. A., Maracaja-Coutinho, V., Ho-Xuan, H., Meister, G., Chiong, M., Ocaranza, M. P., Corvalán, A. H., Parra, V., & Lavandero, S. (2020). Angiotensin-(1–9) prevents cardiomyocyte hypertrophy by controlling mitochondrial dynamics via miR-129-3p/PKIA pathway. Cell Death & Differentiation. https://doi.org/10.1038/s41418-020-0522-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.